Teligent Operating Income 2010-2021 | TLGT
Teligent operating income from 2010 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Teligent Annual Operating Income
(Millions of US $) |
| 2020 |
$-140 |
| 2019 |
$-8 |
| 2018 |
$-15 |
| 2017 |
$-12 |
| 2016 |
$3 |
| 2015 |
$-3 |
| 2014 |
$4 |
| 2013 |
$-0 |
| 2012 |
$-3 |
| 2011 |
$-3 |
| 2010 |
$-4 |
| 2009 |
$-4 |
Teligent Quarterly Operating Income
(Millions of US $) |
| 2021-06-30 |
$-11 |
| 2021-03-31 |
$-9 |
| 2020-12-31 |
$-109 |
| 2020-09-30 |
$-9 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$-18 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-5 |
| 2018-09-30 |
$-1 |
| 2018-06-30 |
$-5 |
| 2018-03-31 |
$-4 |
| 2017-12-31 |
$-7 |
| 2017-09-30 |
$-8 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$3 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$1 |
| 2016-03-31 |
$1 |
| 2015-12-31 |
$-3 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$4 |
| 2014-09-30 |
$-0 |
| 2014-06-30 |
$-0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$-0 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-1 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
